Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLDN19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SEMA4F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00982 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC105 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UST-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FUT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEFA1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GIMAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUNDC3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S1PR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTMR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIPK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC17A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCSK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLYAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PNMA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on